Bisethylnorspermine lipopolyamine as potential delivery vector for combination drug/gene anticancer therapies

Yanmei Dong, Jing Li, Chao Wu, David Oupický

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Purpose: To design novel synthetic gene delivery system in which the carrier molecule functions dually as a carrier and a cytotoxic agent targeting dysregulated polyamine metabolism in cancer. Methods: Bisethylnorspermine (BENSpm) lipopolyamine was synthesized and its toxicity evaluated by MTS assay in MCF-7 and MCF-10A cells. Transfection activity was determined using luciferase plasmid DNA. Results: Asymmetrical lipid analogue of polyamine anticancer drug BENSpm was synthesized using nucleophilic ring opening of azetidinium ion. The synthesized LipoBENSpm showed cytotoxicity comparable to that of parent BENSpm in human breast cancer cell line MCF-7 but mediated 3-4 orders magnitude higher transfection activity. Importantly, cytostatic activity of BENSpm, typically in a low μM range, falls within a relevant and typical concentration range required for efficient gene delivery. Conclusions: These findings make gene delivery vectors based on BENSpm promising candidates for combination drug/gene approaches to the treatment of cancer.

Original languageEnglish (US)
Pages (from-to)1927-1938
Number of pages12
JournalPharmaceutical Research
Issue number9
StatePublished - Sep 2010
Externally publishedYes


  • drug combination
  • drug delivery
  • gene delivery
  • lipid
  • transfection

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)


Dive into the research topics of 'Bisethylnorspermine lipopolyamine as potential delivery vector for combination drug/gene anticancer therapies'. Together they form a unique fingerprint.

Cite this